TREM1 and glioblastoma: In cohorts of patients with liver hepatocellular carcinoma (LIHC) and glioblastoma multiform (GBM), high TREM1 expression was associated with worse overall survival and positively correlated with immune trafficking and myeloid cell recruitment.